Destiny Pharma

www.destinypharma.com TICKER: DEST     EXCHANGE: AIM

Destiny Pharma is dedicated to the discovery, development and commercialisation of new antimicrobials that have unique properties to improve outcomes for patients and the delivery of medical care into the future.

LATEST REPORTS

 
Investor Forum November 2017
Published: Nov 30 2017

Neil Clark, CEO, discusses the Group's activity post-IPO and addresses  the firm's plans going forward.

REGISTER / LOGIN TO VIEW THIS RESEARCH IN FULL

ARCHIVE